ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 816

TRNT1 Missense Mutations Define a New Periodic Fever Syndrome

Angeliki Giannelou1, Qing Zhou2, Monique Stoffels3, Amanda Ombrello4, Deborah Stone2, Jehad H. Edwan5, Martin Pelletier6, Wanxia Tsai7, Katherine Calvo8, Sergio Rosenzweig9, Karyl Barron10, Massimo Gadina11, Ivona Aksentijevich12 and Daniel L. Kastner13, 1National Institute for Arthritis and Musculoskeletal and Skin Diseases, bethesda, MD, 2National Human Genome Research Institute, Bethesda, MD, 3National Human Genome Research Institute, bethesda, MD, 4Inflammatory Diseases Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 5NIAMS NIH, Bethesda, MD, 6Niams, Immunoregulation Section, Autoimmunity Branch, Bethesda, MD, 7Translational Immunology Section, NIAMS / NIH, Bethesda, MD, 8Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD, 9National Institute of Allergy and Infectious Diseases, Bethesda, MD, 10NIH, Bethesda, MD, 11NIAMS/NIH, Bethesda, MD, 12Inflammatory Diseases Section, National Human Genome Research Institute, Bethesda, MD, 13Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autoimmunity and genetic disorders

  • Tweet
  • Email
  • Print
Session Information

Title: ACR Plenary Session I: Discovery 2014

Session Type: Plenary Sessions

Background/Purpose

Two thirds of the 1700 patients seen at our NIH clinic for autoinflammatory diseases do not have a genetic diagnosis.  Whole exome sequencing permits analysis of most of the protein coding regions of the human genome.

Methods

With the use of whole exome sequencing and candidate gene screening, we identified five children from four unrelated families, who had unexplained autoinflammatory disease and shared mutations in one common gene.  One family from Saudi Arabia was consanguineous with two affected daughters.  The second family of mixed Czech and British background had one affected boy.  The third and fourth families were of mixed European ancestry from the United States and each family had one affected daughter.  We performed additional experiments in patients samples including flow cytometry, immunophenotyping, cytokine profiling, mitochondria related function and ribosomal assembly assays.  Protein function was studied with morpholino knockdowns in zebrafish embryos.

Results

All patients carried missense recessive mutations in one common gene, the TRNT1 (tRNA Nucleotidyl Transferase, CCA-Adding, 1), on chromosome 3.  The two affected Saudi Arabian sisters were homozygous for a p.H215R missense mutation, while the other three children were compound heterozygous for a missense mutation, p. I223T or p. R99W, and one shared mutation p.D163V. The p.H215R mutation was not found in any public database neither in 1061 Arab control DNA samples.  From the three Caucasian mutations, the p.R99W was novel whereas the p. I223T and p.D163V were found at a very low allele frequency (<0.001) at the NHLBI exomedatabase. All mutations affect highly conserved amino acid residues and are predicted to be damaging to the protein function.  All children had recurrent episodes of high fevers with negative sepsis work up that occurred in association with microcytic anemia, and a spectrum of multisystem features.  Neurologic involvement ranged from mild developmental delay to nystagmus, hypotonia, optic nerve atrophy, and sensorineural hearing loss.  Other variables manifestations include dysmorphic features, musculoskeletal and gastrointestinal symptoms, B cell immunodeficiency and hypogammaglobulinemia.  Studies performed so far, point towards a maturation defect of the B cell lineage in the bone marrow, as a possible cause of the observed immunodeficiency. Preliminary data from cytokine analysis in two patients have shown elevated levels of the proinflammatory cytokines interleukin 6 and type 1interferon, suggesting possible therapeutic targets.  Knockdown of the zebrafish TRNT1 homologue caused hydrocephaly, defects in tail development, anemia and a reduction in the number of hair cells present in the lateral line, that has function resembling human inner ear.

Conclusion

The CCA-adding TRNT1 enzyme catalyzes the addition of the CCA terminus to the 3 prime end of all tRNAs precursors, a step that is essential for tRNA aminoacylation and protein synthesis. The discovery that missense mutations in this essential and ubiquitiously expressed gene cause a newly defined periodic fever syndrome , will allow further understanding of mechanisms underlying inflammation.


Disclosure:

A. Giannelou,
None;

Q. Zhou,
None;

M. Stoffels,
None;

A. Ombrello,
None;

D. Stone,
None;

J. H. Edwan,
None;

M. Pelletier,
None;

W. Tsai,
None;

K. Calvo,
None;

S. Rosenzweig,
None;

K. Barron,
None;

M. Gadina,
None;

I. Aksentijevich,
None;

D. L. Kastner,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trnt1-missense-mutations-define-a-new-periodic-fever-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology